Automated Clinical Pathway for Inflammatory Bowel Disease Care

Effect of an Automated Clinical Pathway Utilizing Tailored Risk Stratification on Rates of Overdue Follow up and Outcomes in Patients With Inflammatory Bowel Disease

Pragmatic randomized controlled trial to evaluate the effect of an electronic medical record-based tool on improving on-time follow up and its effects on inflammatory bowel disease outcomes

Inclusion Criteria:

1. Alive patients with 2 or more visits to the UT Southwestern adult digestive disease clinic within 3 years of the date of trial commencement including at least one visit within 2 years, and

2. An active inflammatory bowel disease-specific medication, and

3. At least one of the following:

   1. Inflammatory bowel disease on the active problem list
   2. An inflammatory bowel disease invoice diagnosis at least twice in the 3 years prior to trial commencement
   3. An inflammatory bowel disease encounter diagnosis at least twice in the 3 years prior to trial commencement

Exclusion Criteria:

Patients not meeting inclusion criteria